New research identifies MG53 (TRIM72) as a key regulator of muscle stem cell activation in ageing, and a promising therapeutic target for sarcopenia. Here’s what the science shows.
25+ scientists published a coordinated expert review in Nature Aging confirming NAD+ as a central target in aging research. Here’s what the evidence says about NMN, NR, and the case for NAD+ augmentation.
VITAL-H is a $38 million federally funded trial testing rapamycin, semaglutide, and dapagliflozin in 700–1,000 healthy adults aged 60–65. Here’s what it’s measuring and why it matters.
Thymalin, Pinealon, and Vilon are ultra-short bioregulator peptides developed over 40 years by Vladimir Khavinson. Here’s what the clinical data shows.
GHK-Cu is one of the most-studied peptides in existence. Here’s what five decades of research actually shows — mechanism, findings, and where the science stands in 2026.
For laboratory and research use only. Introduction Cellular senescence is one of the more active areas in ageing biology right now. Senescent cells — those that have permanently exited the cell cycle — accumulate with age and are associated with tissue dysfunction across organ systems. The standard picture is of senescent cells as isolated problem […]
On September 19, 2025, a four-amino-acid peptide became the first approved drug to directly target the inside of a mitochondrion. That sentence probably doesn’t sound as consequential as it is. So let’s unpack it. — ## What is elamipretide? Elamipretide — also known as SS-31, MTP-131, and by the brand name Stealth — is a […]
Epithalon is a synthetic tetrapeptide with a 40-year research history. We examine the evidence on telomerase activation, lifespan extension in animal models, and the long-term human observational data from Khavinson’s group.
GLP-1 peptides like semaglutide and tirzepatide show promise beyond weight loss. Explore the emerging longevity, neuroprotection and anti-ageing research findings.
The global peptide therapeutics market could reach \$300 billion by 2033. Discover the GLP-1 effect, emerging research trends, and what the peptide boom means for science.
